Efficient Multisite Unnatural Amino Acid Incorporation in Mammalian Cells via Optimized Pyrrolysyl tRNA Synthetase/tRNA Expression and Engineered eRF1
Open Access
- 28 October 2014
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 136 (44) , 15577-15583
Abstract
The efficient, site-specific introduction of unnatural amino acids into proteins in mammalian cells is an outstanding challenge in realizing the potential of genetic code expansion approaches. Addressing this challenge will allow the synthesis of modified recombinant proteins and augment emerging strategies that introduce new chemical functionalities into proteins to control and image their function with high spatial and temporal precision in cells. The efficiency of unnatural amino acid incorporation in response to the amber stop codon (UAG) in mammalian cells is commonly considered to be low. Here we demonstrate that tRNA levels can be limiting for unnatural amino acid incorporation efficiency, and we develop an optimized pyrrolysyl-tRNA synthetase/tRNACUA expression system, with optimized tRNA expression for mammalian cells. In addition, we engineer eRF1, that normally terminates translation on all three stop codons, to provide a substantial increase in unnatural amino acid incorporation in response to the UAG codon without increasing readthrough of other stop codons. By combining the optimized pyrrolysyl-tRNA synthetase/tRNACUA expression system and an engineered eRF1, we increase the yield of protein bearing unnatural amino acids at a single site 17- to 20-fold. Using the optimized system, we produce proteins containing unnatural amino acids with comparable yields to a protein produced from a gene that does not contain a UAG stop codon. Moreover, the optimized system increases the yield of protein, incorporating an unnatural amino acid at three sites, from unmeasurably low levels up to 43% of a no amber stop control. Our approach may enable the efficient production of site-specifically modified therapeutic proteins, and the quantitative replacement of targeted cellular proteins with versions bearing unnatural amino acids that allow imaging or synthetic regulation of protein function.Keywords
Funding Information
- Medical Research Council (U105181009, UD99999908)
- Directorate-General for Research and Innovation
- European Molecular Biology Organization (ALTF 1232-2011)
This publication has 42 references indexed in Scilit:
- Two-step model of stop codon recognition by eukaryotic release factor eRF1Nucleic Acids Research, 2013
- Identification of eRF1 residues that play critical and complementary roles in stop codon recognitionRNA, 2012
- RF1 knockout allows ribosomal incorporation of unnatural amino acids at multiple sitesNature Chemical Biology, 2011
- A single amino acid change of translation termination factor eRF1 switches between bipotent and omnipotent stop-codon specificity †Nucleic Acids Research, 2010
- Codon reassignment in the Escherichia coli genetic codeNucleic Acids Research, 2010
- A Facile System for Encoding Unnatural Amino Acids in Mammalian CellsAngewandte Chemie International Edition, 2009
- Structural insights into eRF3 and stop codon recognition by eRF1Genes & Development, 2009
- Different modes of stop codon restriction by the Stylonychia and Paramecium eRF1 translation termination factorsProceedings of the National Academy of Sciences, 2007
- Crystal Structures of the Ribosome in Complex with Release Factors RF1 and RF2 Bound to a Cognate Stop CodonCell, 2005
- Release factors differing in specificity for terminator codons.Proceedings of the National Academy of Sciences, 1968